Cargando…
Regulatory T cells control toxicity in a humanized model of IL-2 therapy
While patient selection and clinical management have reduced high-dose IL-2 (HDIL2) immunotherapy toxicities, the immune mechanisms that underlie HDIL2-induced morbidity remain unclear. Here we show that dose-dependent morbidity and mortality of IL-2 immunotherapy can be modeled in human immune syst...
Autores principales: | Li, Yan, Strick-Marchand, Helene, Lim, Ai Ing, Ren, Jiazi, Masse-Ranson, Guillemette, Dan Li, Jouvion, Gregory, Rogge, Lars, Lucas, Sophie, Bin Li, Di Santo, James P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701141/ https://www.ncbi.nlm.nih.gov/pubmed/29176694 http://dx.doi.org/10.1038/s41467-017-01570-9 |
Ejemplares similares
-
A Novel Mouse Model for Stable Engraftment of a Human Immune System and Human Hepatocytes
por: Strick-Marchand, Helene, et al.
Publicado: (2015) -
Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver
por: Dusséaux, Mathilde, et al.
Publicado: (2017) -
IL-12 drives functional plasticity of human group 2 innate lymphoid cells
por: Lim, Ai Ing, et al.
Publicado: (2016) -
Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies
por: Bianchi, Elisabetta, et al.
Publicado: (2021) -
‘ILC-poiesis’: generating tissue ILCs from naïve precursors
por: Di Santo, James P., et al.
Publicado: (2017)